Emalex Biosciences

Emalex Biosciences is a pharmaceutical company based in Chicago, Illinois, United States, that focuses on developing new treatments for rare and orphan neurological conditions, with a particular emphasis on Tourette Syndrome. The company is currently conducting late-stage clinical trials for a new class of drug to address the unmet needs of patients with limited treatment options.